Collegium Pharma (COLL)

$32.69 +1.63 (5.25%)
Market Cap 988.59M
Revenue (ttm) 780.57M
Net Income (ttm) 62.87M
EPS (ttm) N/A
PE Ratio 4.62
Forward PE 4.70
Profit Margin 8.05%
Debt to Equity Ratio 1.81
Volume 350,100
Avg Vol 523,728
Day's Range N/A - N/A
Shares Out 32.43M
Stochastic %K 29%
Beta 0.74
Analysts Strong Sell
Price Target $54.33

Company Profile

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-dete...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 781 713 3699
Address:
100 Technology Center Drive, Suite 300, Stoughton, United States
Estimize
Estimize Jun. 1 at 1:03 PM
Wall St is expecting 1.72 EPS for $COLL Q2 [Reporting 07/30 BMO] http://www.estimize.com/intro/coll?chart=historical&metric_name=eps&utm_co
0 · Reply
jewell69
jewell69 May. 21 at 5:16 PM
trying 2 by 400 $ONDS now b a .08 x .09 got my 100 $COLL replaced at 34.08 took a skinny profit 5/14 at 35.26
0 · Reply
jewell69
jewell69 May. 21 at 1:45 AM
$VRTX Tonight's NHL game, Las Vegas at Colorado Avalanche is showing 2 long long ads for JOURNAVX non-addictive pain medicine. sort of similar to the drugs from $COLL
2 · Reply
SuperGreenToday
SuperGreenToday May. 18 at 5:23 PM
$COLL Share Price: $34.31 Contract Selected: Dec 18, 2026 $35 Calls Buy Zone: $3.82 – $4.73 Target Zone: $7.08 – $8.65 Potential Upside: 75% ROI Time to Expiration: 213 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
jewell69
jewell69 May. 18 at 4:21 PM
9.80 3/11 the highest price we paid for $ONDS and still made money Today 5/8 trying 2 by 300 9.58 now b a .62 x .63 12.19 pm edt Low 4 day so far 9.50 Took skinny profits in $COLL 202 at 34.69
0 · Reply
Estimize
Estimize May. 18 at 1:06 PM
Wall St is expecting 1.72 EPS for $COLL Q2 [Reporting 07/30 BMO] http://www.estimize.com/intro/coll?chart=historical&metric_name=eps&utm_co
0 · Reply
jewell69
jewell69 May. 13 at 6:21 PM
indeed, we lost on $COLL when we invested in it in the 40's. been able to squeak out some profit in the 30's. NOTE; big bump that came back to earth today after earnings beat of 10%+ 05/13/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 100 $35.12 -$3,512.00 More 04/20/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 100 $35.27 $0.09 $3,526.91 More 02/26/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 80 $44.22 -$3,537.60 More 02/23/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 20 $44.30 -$886.00 More 01/09/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 40 $46.04 $0.01 $1,841.59 More 01/09/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 40 $45.29 -$1,811.60 Mor
0 · Reply
OpenOutcrier
OpenOutcrier May. 7 at 12:30 PM
$COLL (+4.1% pre) Collegium Pharmaceutical (NASDAQ:COLL) Exceeds Q1 CY2026 Expectations, Stock Soars https://ooc.bz/l/101398
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 7 at 11:38 AM
$COLL Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.45 up 462.50% YoY • Reported revenue of $193.52M up 8.87% YoY
0 · Reply
Estimize
Estimize Apr. 30 at 1:00 PM
Wall St is expecting 1.52 EPS for $COLL Q1 [Reporting 05/07 BMO] http://www.estimize.com/intro/coll?chart=historical&metric_name=eps&utm_co
0 · Reply
Latest News on COLL
Collegium Pharmaceutical Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 1:20 PM EDT - 1 day ago

Collegium Pharmaceutical Transcript: Jefferies Global Healthcare Conference 2026

Collegium to Participate in 2026 Jefferies Global Healthcare Conference

May 27, 2026, 8:00 AM EDT - 8 days ago

Collegium to Participate in 2026 Jefferies Global Healthcare Conference

Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics

May 12, 2026, 7:31 AM EDT - 23 days ago

Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics

Collegium Pharmaceutical reports Q1 EPS $1.76, consensus $1.52

2026-05-07T12:35:00.000Z - 4 weeks ago

Collegium Pharmaceutical reports Q1 EPS $1.76, consensus $1.52

Collegium Pharmaceutical backs FY26 revenue view $805M-$825M, consensus $839.15M

2026-05-07T12:32:30.000Z - 4 weeks ago

Collegium Pharmaceutical backs FY26 revenue view $805M-$825M, consensus $839.15M

Collegium Pharmaceutical Earnings Call Transcript: Q1 2026

May 7, 2026, 8:00 AM EDT - 4 weeks ago

Collegium Pharmaceutical Earnings Call Transcript: Q1 2026

Collegium Pharmaceutical Earnings release: Q1 2026

May 7, 2026, 8:00 AM EDT - 4 weeks ago

Collegium Pharmaceutical Earnings release: Q1 2026

Collegium Pharmaceutical Quarterly report: Q1 2026

May 7, 2026, 8:00 AM EDT - 4 weeks ago

Collegium Pharmaceutical Quarterly report: Q1 2026

Collegium Pharmaceutical Slides: Q1 2026

May 7, 2026, 8:00 AM EDT - 4 weeks ago

Collegium Pharmaceutical Slides: Q1 2026

Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress

May 7, 2026, 7:30 AM EDT - 4 weeks ago

Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress

Collegium to Report First Quarter 2026 Financial Results on May 7, 2026

Apr 23, 2026, 8:00 AM EDT - 6 weeks ago

Collegium to Report First Quarter 2026 Financial Results on May 7, 2026

Collegium Pharmaceutical Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 15, 2026, 2:15 PM EDT - 7 weeks ago

Collegium Pharmaceutical Transcript: 25th Annual Needham Virtual Healthcare Conference

Collegium to Participate in Upcoming Investor Conferences

Apr 8, 2026, 8:00 AM EDT - 2 months ago

Collegium to Participate in Upcoming Investor Conferences

Collegium Pharmaceutical Proxy statement: Proxy filing

Apr 7, 2026, 8:00 AM EDT - 2 months ago

Collegium Pharmaceutical Proxy statement: Proxy filing

Collegium Pharmaceutical Transcript: M&A announcement

Mar 19, 2026, 9:00 AM EDT - 2 months ago

Collegium Pharmaceutical Transcript: M&A announcement

Collegium Pharmaceutical Press release: M&A announcement

Mar 19, 2026, 9:00 AM EDT - 2 months ago

Collegium Pharmaceutical Press release: M&A announcement

Collegium Pharmaceutical Slides: M&A announcement

Mar 19, 2026, 9:00 AM EDT - 2 months ago

Collegium Pharmaceutical Slides: M&A announcement

Collegium Pharmaceutical to acquire AZSTARYS for $650M in cash

2026-03-19T12:21:54.000Z - 2 months ago

Collegium Pharmaceutical to acquire AZSTARYS for $650M in cash

Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory

Mar 19, 2026, 8:00 AM EDT - 2 months ago

Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory

Collegium Pharmaceutical Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 11, 2026, 9:00 AM EDT - 3 months ago

Collegium Pharmaceutical Transcript: Barclays 28th Annual Global Healthcare Conference

Collegium to Present New Real-World Data at PainConnect 2026

Mar 5, 2026, 8:00 AM EST - 3 months ago

Collegium to Present New Real-World Data at PainConnect 2026

Collegium, Paris Hilton announce ‘Embrace Your Sparkle’ campaign

2026-03-03T13:37:28.000Z - 3 months ago

Collegium, Paris Hilton announce ‘Embrace Your Sparkle’ campaign

Collegium Pharmaceutical Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:00 AM EST - 3 months ago

Collegium Pharmaceutical Earnings Call Transcript: Q4 2025

Collegium Pharmaceutical Annual report: Q4 2025

Feb 26, 2026, 8:00 AM EST - 3 months ago

Collegium Pharmaceutical Annual report: Q4 2025

Collegium Pharmaceutical Earnings release: Q4 2025

Feb 26, 2026, 8:00 AM EST - 3 months ago

Collegium Pharmaceutical Earnings release: Q4 2025

Collegium Pharmaceutical Slides: Q4 2025

Feb 26, 2026, 8:00 AM EST - 3 months ago

Collegium Pharmaceutical Slides: Q4 2025

Collegium Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $2.14

2026-02-26T12:48:39.000Z - 3 months ago

Collegium Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $2.14

Collegium Pharmaceutical sees FY26 product revenue $805M-$825M

2026-02-26T12:48:05.000Z - 3 months ago

Collegium Pharmaceutical sees FY26 product revenue $805M-$825M

Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results

Feb 26, 2026, 7:30 AM EST - 3 months ago

Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results

Collegium Pharmaceutical enters multiyear partnership with Boston Legacy FC

2026-02-23T13:23:08.000Z - 3 months ago

Collegium Pharmaceutical enters multiyear partnership with Boston Legacy FC

Collegium Pharmaceutical price target raised to $58 from $55 at Truist

2026-02-10T14:26:23.000Z - 4 months ago

Collegium Pharmaceutical price target raised to $58 from $55 at Truist

Collegium Pharmaceutical management to meet with Truist

2026-02-05T17:45:46.000Z - 4 months ago

Collegium Pharmaceutical management to meet with Truist

Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference

Jan 15, 2026, 8:00 AM EST - 5 months ago

Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference

Collegium price target lowered to $56 from $58 at Barclays

2026-01-09T12:26:09.000Z - 5 months ago

Collegium price target lowered to $56 from $58 at Barclays

Collegium Pharmaceutical price target raised to $60 from $46 at H.C. Wainwright

2026-01-09T11:16:36.000Z - 5 months ago

Collegium Pharmaceutical price target raised to $60 from $46 at H.C. Wainwright

Collegium Pharmaceutical sees FY26 produce revenue $805M-$825M

2026-01-08T13:11:33.000Z - 5 months ago

Collegium Pharmaceutical sees FY26 produce revenue $805M-$825M

Collegium Provides 2026 Financial Guidance and Business Update

Jan 8, 2026, 8:00 AM EST - 5 months ago

Collegium Provides 2026 Financial Guidance and Business Update

Collegium Pharmaceutical price target raised to $55 from $47 at Truist

2026-01-07T12:25:47.000Z - 5 months ago

Collegium Pharmaceutical price target raised to $55 from $47 at Truist

Collegium Pharmaceutical closes $980M syndicated credit facility

2025-12-30T13:10:23.000Z - 5 months ago

Collegium Pharmaceutical closes $980M syndicated credit facility

Collegium Announces the Closing of $980 Million Syndicated Credit Facility

Dec 30, 2025, 8:00 AM EST - 5 months ago

Collegium Announces the Closing of $980 Million Syndicated Credit Facility

Collegium Pharmaceutical initiated with an Overweight at Barclays

2025-12-08T21:31:51.000Z - 6 months ago

Collegium Pharmaceutical initiated with an Overweight at Barclays

Collegium Pharmaceutical Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 2, 2025, 2:30 PM EST - 6 months ago

Collegium Pharmaceutical Transcript: Piper Sandler 37th Annual Healthcare Conference

Collegium Pharmaceutical Transcript: Jefferies London Healthcare Conference 2025

Nov 19, 2025, 3:00 AM EST - 7 months ago

Collegium Pharmaceutical Transcript: Jefferies London Healthcare Conference 2025

Collegium Pharmaceutical price target raised to $48 from $45 at Truist

2025-11-08T22:45:11.000Z - 7 months ago

Collegium Pharmaceutical price target raised to $48 from $45 at Truist

Collegium Pharmaceutical price target raised to $46 from $44 at H.C. Wainwright

2025-11-07T11:10:13.000Z - 7 months ago

Collegium Pharmaceutical price target raised to $46 from $44 at H.C. Wainwright

Collegium Pharmaceutical Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:00 AM EST - 7 months ago

Collegium Pharmaceutical Earnings Call Transcript: Q3 2025

Collegium Pharmaceutical Quarterly report: Q3 2025

Nov 6, 2025, 8:00 AM EST - 7 months ago

Collegium Pharmaceutical Quarterly report: Q3 2025

Collegium Pharmaceutical Earnings release: Q3 2025

Nov 6, 2025, 8:00 AM EST - 7 months ago

Collegium Pharmaceutical Earnings release: Q3 2025

Collegium Pharmaceutical Slides: Q3 2025

Nov 6, 2025, 8:00 AM EST - 7 months ago

Collegium Pharmaceutical Slides: Q3 2025

Collegium Pharmaceutical reports Q3 adjusted EPS $2.25, consensus $1.86

2025-11-06T12:40:59.000Z - 7 months ago

Collegium Pharmaceutical reports Q3 adjusted EPS $2.25, consensus $1.86

Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance

Nov 6, 2025, 7:30 AM EST - 7 months ago

Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance

Knight Therapeutics Announces Launch of JORNAY PM™ in Canada

Oct 30, 2025, 5:15 PM EDT - 7 months ago

Knight Therapeutics Announces Launch of JORNAY PM™ in Canada

Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 23, 2025, 8:00 AM EDT - 8 months ago

Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025

Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences

Oct 22, 2025, 8:00 AM EDT - 8 months ago

Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences

Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing

Oct 13, 2025, 8:00 AM EDT - 8 months ago

Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing

Collegium Pharmaceutical Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 9, 2025, 10:30 AM EDT - 9 months ago

Collegium Pharmaceutical Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Collegium Pharmaceutical Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 8, 2025, 2:35 PM EDT - 9 months ago

Collegium Pharmaceutical Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting

Aug 25, 2025, 8:00 AM EDT - 10 months ago

Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting

Collegium Pharmaceutical Earnings Call Transcript: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 10 months ago

Collegium Pharmaceutical Earnings Call Transcript: Q2 2025

Collegium Pharmaceutical Quarterly report: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 10 months ago

Collegium Pharmaceutical Quarterly report: Q2 2025

Collegium Pharmaceutical Earnings release: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 10 months ago

Collegium Pharmaceutical Earnings release: Q2 2025

Collegium Pharmaceutical Slides: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 10 months ago

Collegium Pharmaceutical Slides: Q2 2025

Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook

Aug 7, 2025, 7:30 AM EDT - 10 months ago

Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook

Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 24, 2025, 8:00 AM EDT - 11 months ago

Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025

Collegium Announces $150 Million Share Repurchase Program

Jul 7, 2025, 8:00 AM EDT - 11 months ago

Collegium Announces $150 Million Share Repurchase Program

Collegium Pharmaceutical Transcript: Jefferies Global Healthcare Conference 2025

Jun 5, 2025, 1:25 PM EDT - 1 year ago

Collegium Pharmaceutical Transcript: Jefferies Global Healthcare Conference 2025

Collegium Pharmaceutical Slides: FY 2025

Jun 5, 2025, 1:25 PM EDT - 1 year ago

Collegium Pharmaceutical Slides: FY 2025

Collegium Announces $25 Million Accelerated Share Repurchase Program

May 12, 2025, 8:05 AM EDT - 1 year ago

Collegium Announces $25 Million Accelerated Share Repurchase Program

Collegium Pharmaceutical Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Collegium Pharmaceutical Earnings Call Transcript: Q1 2025

Collegium Pharmaceutical Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Collegium Pharmaceutical Quarterly report: Q1 2025

Collegium Pharmaceutical Earnings release: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Collegium Pharmaceutical Earnings release: Q1 2025

Collegium Pharmaceutical Slides: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Collegium Pharmaceutical Slides: Q1 2025

Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress

May 8, 2025, 4:01 PM EDT - 1 year ago

Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress

Collegium to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 24, 2025, 8:00 AM EDT - 1 year ago

Collegium to Report First Quarter 2025 Financial Results on May 8, 2025

Collegium Pharmaceutical Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 8, 2025, 9:30 AM EDT - 1 year ago

Collegium Pharmaceutical Transcript: 24th Annual Needham Virtual Healthcare Conference

Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference

Collegium Pharmaceutical Proxy statement: Proxy Filing

Mar 28, 2025, 8:00 AM EDT - 1 year ago

Collegium Pharmaceutical Proxy statement: Proxy Filing

Collegium Pharmaceutical Proxy statement: Proxy Filing

Mar 28, 2025, 8:00 AM EDT - 1 year ago

Collegium Pharmaceutical Proxy statement: Proxy Filing

Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine's Annual Meeting

Mar 27, 2025, 8:00 AM EDT - 1 year ago

Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine's Annual Meeting

Collegium Announces Updates to its Board of Directors and Executive Leadership Team

Mar 17, 2025, 7:00 AM EDT - 1 year ago

Collegium Announces Updates to its Board of Directors and Executive Leadership Team

Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

Mar 10, 2025, 6:57 PM EDT - 1 year ago

Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

Collegium Pharmaceutical Earnings Call Transcript: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Collegium Pharmaceutical Earnings Call Transcript: Q4 2024

Collegium Pharmaceutical Annual report: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Collegium Pharmaceutical Annual report: Q4 2024

Collegium Pharmaceutical Earnings release: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Collegium Pharmaceutical Earnings release: Q4 2024

Collegium Pharmaceutical Slides: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Collegium Pharmaceutical Slides: Q4 2024

Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results

Feb 27, 2025, 4:01 PM EST - 1 year ago

Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results

Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

Feb 13, 2025, 8:00 AM EST - 1 year ago

Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

Collegium Provides 2025 Financial Guidance and Business Update

Jan 8, 2025, 8:00 AM EST - 1 year ago

Collegium Provides 2025 Financial Guidance and Business Update

Collegium Pharmaceutical Transcript: Piper Sandler 36th Annual Healthcare Conference

Dec 5, 2024, 1:00 PM EST - 1 year ago

Collegium Pharmaceutical Transcript: Piper Sandler 36th Annual Healthcare Conference

Collegium Pharmaceutical Transcript: Jefferies London Healthcare Conference 2024

Nov 19, 2024, 8:30 AM EST - 1 year ago

Collegium Pharmaceutical Transcript: Jefferies London Healthcare Conference 2024

Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD)

Nov 14, 2024, 4:30 PM EST - 1 year ago

Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD)

Collegium Pharmaceutical Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Collegium Pharmaceutical Earnings Call Transcript: Q3 2024

Collegium Pharmaceutical Quarterly report: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Collegium Pharmaceutical Quarterly report: Q3 2024

Collegium Pharmaceutical Earnings release: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Collegium Pharmaceutical Earnings release: Q3 2024

Collegium Pharmaceutical Slides: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Collegium Pharmaceutical Slides: Q3 2024

Collegium Reports Record Third Quarter 2024 Financial Results

Nov 7, 2024, 4:02 PM EST - 1 year ago

Collegium Reports Record Third Quarter 2024 Financial Results

Collegium Pharmaceutical Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Sep 9, 2024, 12:30 PM EDT - 1 year ago

Collegium Pharmaceutical Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Aug 30, 2024, 8:00 AM EDT - 1 year ago

Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Collegium Pharmaceutical Earnings Call Transcript: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 1 year ago

Collegium Pharmaceutical Earnings Call Transcript: Q2 2024

Collegium Pharmaceutical Quarterly report: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 1 year ago

Collegium Pharmaceutical Quarterly report: Q2 2024

Collegium Pharmaceutical Earnings release: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 1 year ago

Collegium Pharmaceutical Earnings release: Q2 2024

Collegium Pharmaceutical Slides: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 1 year ago

Collegium Pharmaceutical Slides: Q2 2024

Collegium Reports Second Quarter 2024 Financial Results

Aug 8, 2024, 4:01 PM EDT - 1 year ago

Collegium Reports Second Quarter 2024 Financial Results

Collegium Pharmaceutical Transcript: M&A Announcement

Jul 29, 2024, 8:30 AM EDT - 2 years ago

Collegium Pharmaceutical Transcript: M&A Announcement

Collegium Pharmaceutical Press release: M&A Announcement

Jul 29, 2024, 8:30 AM EDT - 2 years ago

Collegium Pharmaceutical Press release: M&A Announcement

Collegium Pharmaceutical Slides: M&A Announcement

Jul 29, 2024, 8:30 AM EDT - 2 years ago

Collegium Pharmaceutical Slides: M&A Announcement

Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology

Jul 29, 2024, 6:00 AM EDT - 2 years ago

Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology

Collegium Pharmaceutical Transcript: Jefferies 2024 Global Healthcare Conference

Jun 5, 2024, 9:30 AM EDT - 2 years ago

Collegium Pharmaceutical Transcript: Jefferies 2024 Global Healthcare Conference

Collegium to Participate in Jefferies Global Healthcare Conference

May 29, 2024, 8:00 AM EDT - 2 years ago

Collegium to Participate in Jefferies Global Healthcare Conference

Collegium Announces $35 Million Accelerated Share Repurchase Program

May 13, 2024, 8:00 AM EDT - 2 years ago

Collegium Announces $35 Million Accelerated Share Repurchase Program

Collegium Pharmaceutical Proxy statement: Proxy Filing

May 10, 2024, 8:00 AM EDT - 2 years ago

Collegium Pharmaceutical Proxy statement: Proxy Filing

Collegium Pharmaceutical Earnings Call Transcript: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Collegium Pharmaceutical Earnings Call Transcript: Q1 2024

Collegium Pharmaceutical Quarterly report: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Collegium Pharmaceutical Quarterly report: Q1 2024

Collegium Pharmaceutical Earnings release: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Collegium Pharmaceutical Earnings release: Q1 2024

Collegium Pharmaceutical Slides: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Collegium Pharmaceutical Slides: Q1 2024

Collegium Reports First Quarter 2024 Financial Results

May 9, 2024, 4:02 PM EDT - 2 years ago

Collegium Reports First Quarter 2024 Financial Results

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024

Apr 25, 2024, 8:00 AM EDT - 2 years ago

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024

Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026

Apr 11, 2024, 8:00 AM EDT - 2 years ago

Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026

Collegium Pharmaceutical Transcript: 23rd Annual Needham Virtual Healthcare Conference

Apr 10, 2024, 3:45 PM EDT - 2 years ago

Collegium Pharmaceutical Transcript: 23rd Annual Needham Virtual Healthcare Conference

Collegium Pharmaceutical Proxy statement: Proxy Filing

Apr 5, 2024, 8:00 AM EDT - 2 years ago

Collegium Pharmaceutical Proxy statement: Proxy Filing

Collegium Pharmaceutical Proxy statement: Proxy Filing

Apr 5, 2024, 8:00 AM EDT - 2 years ago

Collegium Pharmaceutical Proxy statement: Proxy Filing

Collegium Pharmaceutical Earnings Call Transcript: Q4 2023

Feb 22, 2024, 4:30 PM EST - 2 years ago

Collegium Pharmaceutical Earnings Call Transcript: Q4 2023

Collegium Pharmaceutical Annual report: Q4 2023

Feb 22, 2024, 4:30 PM EST - 2 years ago

Collegium Pharmaceutical Annual report: Q4 2023

Collegium Pharmaceutical Earnings release: Q4 2023

Feb 22, 2024, 4:30 PM EST - 2 years ago

Collegium Pharmaceutical Earnings release: Q4 2023

Collegium Pharmaceutical Slides: Q4 2023

Feb 22, 2024, 4:30 PM EST - 2 years ago

Collegium Pharmaceutical Slides: Q4 2023

Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results

Feb 22, 2024, 4:09 PM EST - 2 years ago

Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results

Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024

Feb 8, 2024, 8:00 AM EST - 2 years ago

Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024

Collegium Pharmaceutical Slides: Investor Presentation

Jan 2, 2024, 9:00 AM EST - 2 years ago

Collegium Pharmaceutical Slides: Investor Presentation

Collegium Pharmaceutical Transcript: The Piper Sandler 35th Annual Healthcare Conference

Nov 28, 2023, 4:00 PM EST - 2 years ago

Collegium Pharmaceutical Transcript: The Piper Sandler 35th Annual Healthcare Conference

Appeals Court Upholds PTAB's Finding of Invalidity of Purdue's 961 Patent

Nov 27, 2023, 8:00 AM EST - 2 years ago

Appeals Court Upholds PTAB's Finding of Invalidity of Purdue's 961 Patent

Collegium Pharmaceutical Transcript: 14th Annual Jefferies London Healthcare Conference 2023

Nov 14, 2023, 4:30 AM EST - 2 years ago

Collegium Pharmaceutical Transcript: 14th Annual Jefferies London Healthcare Conference 2023

Collegium Pharmaceutical Earnings Call Transcript: Q3 2023

Nov 7, 2023, 4:30 PM EST - 2 years ago

Collegium Pharmaceutical Earnings Call Transcript: Q3 2023

Collegium Pharmaceutical Quarterly report: Q3 2023

Nov 7, 2023, 4:30 PM EST - 2 years ago

Collegium Pharmaceutical Quarterly report: Q3 2023

Collegium Pharmaceutical Earnings release: Q3 2023

Nov 7, 2023, 4:30 PM EST - 2 years ago

Collegium Pharmaceutical Earnings release: Q3 2023

Collegium Pharmaceutical Slides: Q3 2023

Nov 7, 2023, 4:30 PM EST - 2 years ago

Collegium Pharmaceutical Slides: Q3 2023

Collegium Reports Third Quarter 2023 Financial Results

Nov 7, 2023, 4:01 PM EST - 2 years ago

Collegium Reports Third Quarter 2023 Financial Results

Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023

Oct 24, 2023, 8:00 AM EDT - 2 years ago

Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023

Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023

Aug 28, 2023, 8:00 AM EDT - 3 years ago

Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023

Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026

Aug 24, 2023, 8:00 AM EDT - 3 years ago

Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026

Collegium Announces $50 Million Accelerated Share Repurchase Program

Aug 7, 2023, 7:30 AM EDT - 3 years ago

Collegium Announces $50 Million Accelerated Share Repurchase Program

Collegium Pharmaceutical Earnings Call Transcript: Q2 2023

Aug 3, 2023, 4:30 PM EDT - 3 years ago

Collegium Pharmaceutical Earnings Call Transcript: Q2 2023

Collegium Pharmaceutical Quarterly report: Q2 2023

Aug 3, 2023, 4:30 PM EDT - 3 years ago

Collegium Pharmaceutical Quarterly report: Q2 2023

Collegium Pharmaceutical Earnings release: Q2 2023

Aug 3, 2023, 4:30 PM EDT - 3 years ago

Collegium Pharmaceutical Earnings release: Q2 2023

Collegium Pharmaceutical Slides: Q2 2023

Aug 3, 2023, 4:30 PM EDT - 3 years ago

Collegium Pharmaceutical Slides: Q2 2023

Collegium Reports Record 1H'23 Net Revenue of $280.3 Million, Up 35% Year-over-Year

Aug 3, 2023, 4:01 PM EDT - 3 years ago

Collegium Reports Record 1H'23 Net Revenue of $280.3 Million, Up 35% Year-over-Year

Collegium to Report Second Quarter 2023 Financial Results on August 3, 2023

Jul 20, 2023, 8:00 AM EDT - 3 years ago

Collegium to Report Second Quarter 2023 Financial Results on August 3, 2023

Estimize
Estimize Jun. 1 at 1:03 PM
Wall St is expecting 1.72 EPS for $COLL Q2 [Reporting 07/30 BMO] http://www.estimize.com/intro/coll?chart=historical&metric_name=eps&utm_co
0 · Reply
jewell69
jewell69 May. 21 at 5:16 PM
trying 2 by 400 $ONDS now b a .08 x .09 got my 100 $COLL replaced at 34.08 took a skinny profit 5/14 at 35.26
0 · Reply
jewell69
jewell69 May. 21 at 1:45 AM
$VRTX Tonight's NHL game, Las Vegas at Colorado Avalanche is showing 2 long long ads for JOURNAVX non-addictive pain medicine. sort of similar to the drugs from $COLL
2 · Reply
SuperGreenToday
SuperGreenToday May. 18 at 5:23 PM
$COLL Share Price: $34.31 Contract Selected: Dec 18, 2026 $35 Calls Buy Zone: $3.82 – $4.73 Target Zone: $7.08 – $8.65 Potential Upside: 75% ROI Time to Expiration: 213 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
jewell69
jewell69 May. 18 at 4:21 PM
9.80 3/11 the highest price we paid for $ONDS and still made money Today 5/8 trying 2 by 300 9.58 now b a .62 x .63 12.19 pm edt Low 4 day so far 9.50 Took skinny profits in $COLL 202 at 34.69
0 · Reply
Estimize
Estimize May. 18 at 1:06 PM
Wall St is expecting 1.72 EPS for $COLL Q2 [Reporting 07/30 BMO] http://www.estimize.com/intro/coll?chart=historical&metric_name=eps&utm_co
0 · Reply
jewell69
jewell69 May. 13 at 6:21 PM
indeed, we lost on $COLL when we invested in it in the 40's. been able to squeak out some profit in the 30's. NOTE; big bump that came back to earth today after earnings beat of 10%+ 05/13/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 100 $35.12 -$3,512.00 More 04/20/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 100 $35.27 $0.09 $3,526.91 More 02/26/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 80 $44.22 -$3,537.60 More 02/23/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 20 $44.30 -$886.00 More 01/09/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 40 $46.04 $0.01 $1,841.59 More 01/09/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 40 $45.29 -$1,811.60 Mor
0 · Reply
OpenOutcrier
OpenOutcrier May. 7 at 12:30 PM
$COLL (+4.1% pre) Collegium Pharmaceutical (NASDAQ:COLL) Exceeds Q1 CY2026 Expectations, Stock Soars https://ooc.bz/l/101398
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 7 at 11:38 AM
$COLL Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.45 up 462.50% YoY • Reported revenue of $193.52M up 8.87% YoY
0 · Reply
Estimize
Estimize Apr. 30 at 1:00 PM
Wall St is expecting 1.52 EPS for $COLL Q1 [Reporting 05/07 BMO] http://www.estimize.com/intro/coll?chart=historical&metric_name=eps&utm_co
0 · Reply
jewell69
jewell69 Apr. 22 at 6:42 PM
in grandpa's acct, lots of red ink on $COLL he needs to wait another 28 days before the wash rule expires, ugh ! 04/20/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 100 $35.27 $0.09 $3,526.91 More 02/26/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 80 $44.22 -$3,537.60 More 02/23/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 20 $44.30 -$886.00 More 01/09/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 40 $46.04 $0.01 $1,841.59 More 01/09/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 40 $45.29 -$1,811.60 More Total $0.10 -$866.70 real money losses here, people
0 · Reply
jewell69
jewell69 Apr. 22 at 6:40 PM
$COLL trade history looks pretty good IN THIS ACCT (but) 04/22/2026 Sell Edit cost basis method CRCL CIRCLE INTERNET GROUP INCLASS CLASS A 36 $102.115 $0.09 $3,676.05 More 04/21/2026 Buy CRCL CIRCLE INTERNET GROUP INCLASS CLASS A 36 $100.10 -$3,603.60
0 · Reply
jewell69
jewell69 Apr. 22 at 6:40 PM
ANOTHER CIRCLE $CRCL DAY TRADE, COUPLED WITH A $COLL RE-ENTRY (I finally caught on to just trade coll in the 33's and 34's and just take my losses in grandpa's account where he bought a few shares in the 44's ! )
0 · Reply
tilance
tilance Apr. 22 at 3:17 PM
$COLL opened a position here today...
0 · Reply
topstockalerts
topstockalerts Apr. 22 at 12:19 PM
Morning Movers 🌞 $COLL $ELPW $HCAI $KBSX $POET
0 · Reply
Astrid00
Astrid00 Apr. 22 at 11:52 AM
$COLL $ELPW $HCAI $KBSX $KYTX
0 · Reply
topstockalerts
topstockalerts Apr. 22 at 11:52 AM
Pre Market Top Gainers  $HCAI $ELPW $COLL $KBSX $KYTX
0 · Reply
topstockalerts
topstockalerts Apr. 22 at 11:00 AM
Pre Market Top Gainers $HCAI $ELPW $COLL $KBSX $KYTX
0 · Reply
jewell69
jewell69 Apr. 21 at 4:50 PM
small trades today in Sis' account b 10 $QURE 17.14 b 30 $COLL 33.77 b 36 $CRCL 100.10
0 · Reply
jewell69
jewell69 Apr. 20 at 10:26 PM
$KRE s 4/20 70.93 b 3/10 66.10 divvy 109.28 3/25 on 300 4/20 b $ILF 37.725 (long time, no see ) 4/20 s 100 $COLL 35.27 at a loss 4/20 $FRDM b 62.68 oops s in the 61's last week 1st trade day trade s 35 102.98 b 35 102.12 $CRCL 4/20 close 106.36 As Arsenio Hall would always would say: "things that make you say hmmmm "
0 · Reply
jewell69
jewell69 Apr. 20 at 2:04 PM
$COLL b 75 32.99 4/16 s 25 33.89 4/17 s 25 4/20 34.71 s 25 4/20 34.73 however, this MASKS THE 20 I B 2/23 44.30 and the 80 I b at 44.22 on 2/26
0 · Reply
jewell69
jewell69 Apr. 16 at 4:47 PM
ok ok so I'm down in $COLL (during this iteration ) b 20 44.30 2/23 b 80 44.82 2/26 right f. now 33.14 at 12:41 pm est. trying to buy at 32.99 now b a 33.03 x .19 Got Opium ? non-addictive pain medicine is their forte, plus they are just now (3/10) entering another big area. I forgot what it is.
0 · Reply